2005
DOI: 10.1128/jvi.79.17.11151-11160.2005
|View full text |Cite
|
Sign up to set email alerts
|

Differential Pathogenesis of Primary CCR5-Using Human Immunodeficiency Virus Type 1 Isolates in Ex Vivo Human Lymphoid Tissue

Abstract: In the course of human immunodeficiency virus (HIV) disease, CCR5-utilizing HIV type 1 (HIV-1) variants (R5), which typically transmit infection and dominate its early stages, persist in approximately half of the infected individuals (nonswitch virus patients), while in the other half (switch virus patients), viruses using CXCR4 (X4 or R5X4) emerge, leading to rapid disease progression. Here, we used a system of ex vivo tonsillar tissue to compare the pathogeneses of sequential primary R5 HIV-1 isolates from p… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
19
0
1

Year Published

2006
2006
2013
2013

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 22 publications
(21 citation statements)
references
References 63 publications
1
19
0
1
Order By: Relevance
“…We can speculate that these viruses could have sufficient mutations in V3 to enable them to interact with CXCR4 and thereby activate bystander T cells, even if these viruses could not efficiently infect target cells via CXCR4 and thus did not have an X4 phenotype. This model of X4-like pathogenicity of R5 "late" viruses might be consistent with studies reporting increased pathogenicity in R5-infected patients during latestage disease (22,28,39).…”
Section: Our Investigation Of the Immunological And Virological Detersupporting
confidence: 76%
“…We can speculate that these viruses could have sufficient mutations in V3 to enable them to interact with CXCR4 and thereby activate bystander T cells, even if these viruses could not efficiently infect target cells via CXCR4 and thus did not have an X4 phenotype. This model of X4-like pathogenicity of R5 "late" viruses might be consistent with studies reporting increased pathogenicity in R5-infected patients during latestage disease (22,28,39).…”
Section: Our Investigation Of the Immunological And Virological Detersupporting
confidence: 76%
“…Ϫ subsets was that CD4 ϩ cells are the target cells for HIV-1, and both CD4 and CCR5 are downregulated on cells after infection with HIV-1 (6,22,48). The percentages of CCR5 ϩ CD4 ϩ T cells and concentrations of CCR5 receptors on the surfaces of CD4 ϩ T-cell subsets were significantly related to concentrations of virus within the subsets; log 10 HIV-1 RNA/10 5 cells increased 0.54 (95% CI, 0.33 to 0.74) for each 10% increase in the percentage of CCR5 (Fig.…”
Section: Ccr5 Expression On Cd4mentioning
confidence: 99%
“…However, in 50% of patients there is no switch in coreceptor usage, and although the presence of X4 tropic virus has been associated with poor prognosis in patients, it is evident that the coreceptor switch is not absolutely essential for progression to AIDS (63). Nevertheless, the selection of more pathogenic CCR5 utilizing HIV has been documented.…”
Section: Discussionmentioning
confidence: 99%